McCourt Marion's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Dec 12, 2023
- Accession no.
- 0001883850-23-000088
- Filed
- Dec 12, 2023
- Trade date
- Dec 8-11, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $226.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McCourt MarionCIK 0001663758 | Officer (EVP Commercial) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Common Stock | FTax withholdingDisposed | −852 | $843.79 | −$718,909.08 | 18,951 | Direct | |
| Dec 8, 2023 | Common Stock | AGrant or awardAcquired | +2,133 | $0.00 | $0 | 21,084 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −270 | $838.44 | −$226,378.8 | 20,814 | Direct | |
| Dec 11, 2023 | Common Stock | FTax withholdingDisposed | −373 | $844.09 | −$314,845.57 | 20,441 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Common Stock | AGrant or awardAcquired | +7,649 | $0.00 | $0 | 7,649 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.